Literature DB >> 30206500

Adjuvant, neoadjuvant, and definitive radiation therapy for malignant pleural mesothelioma.

Gwendolyn Cramer1, Charles B Simone2, Theresa M Busch1, Keith A Cengel1.   

Abstract

While ionizing radiotherapy (RT) can provide durable local control, the relative radiosensitivity of surrounding organs such as the lungs and heart and the distributed nature of the pleura limit the ability to safely deliver RT for patients with malignant pleural mesothelioma (MPM). Recent advances in the technological sophistication of RT planning and delivery devices have resulted in increased spatial control of irradiation dose that has extended the palliative and definitive applications of RT for patients with MPM. This review will outline the logistical, mechanistic and clinical basics of RT and the clinical trials supporting the use of RT in the multidisciplinary care of patients with MPM.

Entities:  

Keywords:  Mesothelioma; adjuvant and neoadjuvant hemithoracic radiotherapies; ionizing radiotherapy (ionizing RT); normal tissue radiotolerance; palliative radiotherapy (palliative RT); surgical cytoreduction

Year:  2018        PMID： 30206500      PMCID： PMC6123183          DOI： 10.21037/jtd.2018.07.65

Source DB:  PubMed          Journal:  J Thorac Dis        ISSN： 2072-1439            Impact factor:   2.895


  36 in total

Review 1.  Immunotherapy and radiation therapy for malignant pleural mesothelioma.

Authors:  Evan W Alley; Sharyn I Katz; Keith A Cengel; Charles B Simone
Journal:  Transl Lung Cancer Res       Date:  2017-04

2.  Establishing locoregional control of malignant pleural mesothelioma using high-dose radiotherapy and (18) F-FDG PET/CT scan correlation.

Authors:  Malcolm Feigen; Sze Ting Lee; Catherine Lawford; Katheryn Churcher; Eddy Zupan; Andrew M Scott; Chris Hamilton
Journal:  J Med Imaging Radiat Oncol       Date:  2011-06       Impact factor: 1.735

3.  Stereotactic ablative radiotherapy versus lobectomy for operable stage I non-small-cell lung cancer: a pooled analysis of two randomised trials.

Authors:  Joe Y Chang; Suresh Senan; Marinus A Paul; Reza J Mehran; Alexander V Louie; Peter Balter; Harry J M Groen; Stephen E McRae; Joachim Widder; Lei Feng; Ben E E M van den Borne; Mark F Munsell; Coen Hurkmans; Donald A Berry; Erik van Werkhoven; John J Kresl; Anne-Marie Dingemans; Omar Dawood; Cornelis J A Haasbeek; Larry S Carpenter; Katrien De Jaeger; Ritsuko Komaki; Ben J Slotman; Egbert F Smit; Jack A Roth
Journal:  Lancet Oncol       Date:  2015-05-13       Impact factor: 41.316

4.  Accelerated hemithoracic radiation followed by extrapleural pneumonectomy for malignant pleural mesothelioma.

Authors:  Marc de Perrot; Ronald Feld; Natasha B Leighl; Andrew Hope; Thomas K Waddell; Shaf Keshavjee; B C John Cho
Journal:  J Thorac Cardiovasc Surg       Date:  2015-10-19       Impact factor: 5.209

5.  Multicenter phase II trial of neoadjuvant pemetrexed plus cisplatin followed by extrapleural pneumonectomy and radiation for malignant pleural mesothelioma.

Authors:  Lee M Krug; Harvey I Pass; Valerie W Rusch; Hedy L Kindler; David J Sugarbaker; Kenneth E Rosenzweig; Raja Flores; Joseph S Friedberg; Katherine Pisters; Matthew Monberg; Coleman K Obasaju; Nicholas J Vogelzang
Journal:  J Clin Oncol       Date:  2009-04-13       Impact factor: 44.544

6.  A randomised controlled trial of intervention site radiotherapy in malignant pleural mesothelioma.

Authors:  Noelle O'Rourke; Jose Curto Garcia; Jim Paul; Claire Lawless; Rhona McMenemin; Jennifer Hill
Journal:  Radiother Oncol       Date:  2007-06-22       Impact factor: 6.280

7.  Prevention of malignant seeding after invasive diagnostic procedures in patients with pleural mesothelioma. A randomized trial of local radiotherapy.

Authors:  C Boutin; F Rey; J R Viallat
Journal:  Chest       Date:  1995-09       Impact factor: 9.410

8.  Neoadjuvant chemotherapy and extrapleural pneumonectomy of malignant pleural mesothelioma with or without hemithoracic radiotherapy (SAKK 17/04): a randomised, international, multicentre phase 2 trial.

Authors:  Rolf A Stahel; Oliver Riesterer; Alexandros Xyrafas; Isabelle Opitz; Michael Beyeler; Adrian Ochsenbein; Martin Früh; Richard Cathomas; Kristiaan Nackaerts; Solange Peters; Christoph Mamot; Alfred Zippelius; Carlo Mordasini; Clemens B Caspar; Katrin Eckhardt; Ralph A Schmid; Daniel M Aebersold; Oliver Gautschi; Wolfgang Nagel; Michael Töpfer; Jerome Krayenbuehl; Karin Ribi; Ilja Ciernik; Walter Weder
Journal:  Lancet Oncol       Date:  2015-11-02       Impact factor: 41.316

9.  A randomised trial of single-dose radiotherapy to prevent procedure tract metastasis by malignant mesothelioma.

Authors:  S Bydder; M Phillips; D J Joseph; F Cameron; N A Spry; Y DeMelker; A W Musk
Journal:  Br J Cancer       Date:  2004-07-05       Impact factor: 7.640

10.  Phase II trial of neoadjuvant pemetrexed plus cisplatin followed by surgery and radiation in the treatment of pleural mesothelioma.

Authors:  Rea Federico; Favaretto Adolfo; Marulli Giuseppe; Spaggiari Lorenzo; DePas Tommaso Martino; Ceribelli Anna; Paccagnella Adriano; Crivellari Gino; Russo Francesca; Ceccarelli Matteo; Kazeem Gbenga; Marchi Paolo; Facciolo Francesco
Journal:  BMC Cancer       Date:  2013-01-16       Impact factor: 4.430
View more
  5 in total

1.  Modeling Epidermal Growth Factor Inhibitor-mediated Enhancement of Photodynamic Therapy Efficacy Using 3D Mesothelioma Cell Culture.

Authors:  Gwendolyn Cramer; Michael Shin; Sarah Hagan; Sharyn I Katz; Charles B Simone; Theresa M Busch; Keith A Cengel
Journal:  Photochem Photobiol       Date:  2019-01-07       Impact factor: 3.421

2.  A Novel Prospective Study Assessing the Combination of Photodynamic Therapy and Proton Radiation Therapy: Safety and Outcomes When Treating Malignant Pleural Mesothelioma.

Authors:  Stephanie R Rice; Yun R Li; Theresa M Busch; Michele M Kim; Sally McNulty; Andrea Dimofte; Timothy C Zhu; Keith A Cengel; Charles B Simone
Journal:  Photochem Photobiol       Date:  2018-12-28       Impact factor: 3.421

3.  Surgical staging and resection of malignant pleural mesothelioma.

Authors:  Lawrence B Brown; Frank Corl; Shanda H Blackmon
Journal:  J Thorac Dis       Date:  2020-12       Impact factor: 3.005

4.  Trimodality treatment in malignant pleural mesothelioma - Ordeal or real deal?

Authors:  Naveen Mummudi; Asfiya Khan; Anil Tibdewal; Rajiv Kumar; Sabita Jiwnani; George Karimundackal; C S Pramesh; Jai Prakash Agarwal
Journal:  Rep Pract Oncol Radiother       Date:  2020-08-22

5.  Impact of asbestos on public health: a retrospective study on a series of subjects with occupational and non-occupational exposure to asbestos during the activity of Fibronit plant (Broni, Italy).

Authors:  Silvia D Visonà; Simona Villani; Federica Manzoni; Yao Chen; Giorgio Ardissino; Francesca Russo; Matteo Moretti; Gulnaz T Javan; Antonio Osculati
Journal:  J Public Health Res       Date:  2018-12-20
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.